STIM1 and melanoma: To do so, we constructed a malignant-cell-derived STIM1 score from 277 melanoma specimens with tumor purity (IHC) > 80% (44 primary and 233 metastatic) by averaging the top 100 malignant-cell-derived STIM1-coexpressed profiles.